Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk

Detalhes bibliográficos
Autor(a) principal: Veloso, Denny Fabrício Magalhães
Data de Publicação: 2024
Outros Autores: Veloso, Denise Sena, Andrade, André Felipe Zuccolo Barragat de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/4406
Resumo: Introduction: There is no consensus in the literature on a reasonable delay time from diagnosis to radical prostatectomy (RP) surgery, without worsening the prognosis. Objective: To evaluate the influence of the delay on the risk of disease recurrence in patients with acinar adenocarcinoma of the prostate treated with RP. Method: Four hundred and twelve patients undergoing RP were retrospectively evaluated. Of these, 172 were excluded due to incomplete data and another 28 due to preoperative staging as high-risk prostate cancer (PSA > 10 ng/mL or Gleason score on biopsy > 7). Pre-and postoperative stagings were compared and survival analysis was performed using the Kaplan-Meier method to investigate the influence of time on discordance between pre- and postoperative stagings. Results: For the 212 patients of the sample, the average time from diagnosis to RP was 176.1 ± 120.2 days (median 145.5 days), ranging from 29 to a maximum of 798 days. The Kaplan-Meier curve indicated that the cancer worsened the longer the delay between diagnosis and surgery. Patients undergoing surgery within 60 days had an approximately 95% probability of not increasing the initial risk of recurrence. This number fell to 80%, 70% and 50% in patients operated on up to 100, 120 and 180 days, respectively. Conclusion: Delay in performing RP represents a continuous risk of relapse. The ideal time for RP is up to 60 days from prostate biopsy, as the probability of upstaging is less than 5% in this period.
id INCA-1_9de81dd0172636c55a428576c8f42131
oai_identifier_str oai:rbc.inca.gov.br:article/4406
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence RiskRelación entre el Tiempo de Demora Hasta el Tratamiento Quirúrgico del Cáncer de Próstata y el Riesgo de Recurrencia de la EnfermedadRelação entre Tempo de Atraso no Tratamento Cirúrgico do Câncer de Próstata e Risco de Recorrência da DoençaNeoplasias da PróstataProstatectomiaTempo para o TratamentoProgressão da DoençaRecidiva Local de NeoplasiaProstatic NeoplasmsProstatectomyTime-to-TreatmentDisease ProgressionNeoplasm Recurrence, LocalNeoplasias de la PróstataProstatectomíaTiempo de TratamientoProgresión de la EnfermedadRecurrencia Local de NeoplasiaIntroduction: There is no consensus in the literature on a reasonable delay time from diagnosis to radical prostatectomy (RP) surgery, without worsening the prognosis. Objective: To evaluate the influence of the delay on the risk of disease recurrence in patients with acinar adenocarcinoma of the prostate treated with RP. Method: Four hundred and twelve patients undergoing RP were retrospectively evaluated. Of these, 172 were excluded due to incomplete data and another 28 due to preoperative staging as high-risk prostate cancer (PSA > 10 ng/mL or Gleason score on biopsy > 7). Pre-and postoperative stagings were compared and survival analysis was performed using the Kaplan-Meier method to investigate the influence of time on discordance between pre- and postoperative stagings. Results: For the 212 patients of the sample, the average time from diagnosis to RP was 176.1 ± 120.2 days (median 145.5 days), ranging from 29 to a maximum of 798 days. The Kaplan-Meier curve indicated that the cancer worsened the longer the delay between diagnosis and surgery. Patients undergoing surgery within 60 days had an approximately 95% probability of not increasing the initial risk of recurrence. This number fell to 80%, 70% and 50% in patients operated on up to 100, 120 and 180 days, respectively. Conclusion: Delay in performing RP represents a continuous risk of relapse. The ideal time for RP is up to 60 days from prostate biopsy, as the probability of upstaging is less than 5% in this period.Introducción: Según la literatura, no existe consenso sobre un tiempo razonable de retraso desde el diagnóstico hasta la cirugía de prostatectomía radical (PR), sin empeorar el pronóstico. Objetivo: Evaluar la influencia de este tiempo sobre el riesgo de recurrencia de la enfermedad en pacientes con adenocarcinoma acinar de próstata tratados con PR. Método: Se evaluaron retrospectivamente 412 pacientes sometidos a PR. De ellos, 172 fueron excluidos por datos incompletos y otros 28 por estadificación preoperatoria como cáncer de próstata de alto riesgo (PSA > 10 ng/mL o puntuación de Gleason en la biopsia > 7). Se compararon las estadificaciones pre y posoperatorias y se realizó un análisis de supervivencia utilizando el método de Kaplan-Meier para examinar la influencia del tiempo en la discordancia entre las estadificaciones pre y posoperatorias. Resultados: Para los 212 pacientes de la muestra, el tiempo promedio desde el diagnóstico hasta la PR fue de 176,1 ± 120,2 días (mediana 145,5 días), oscilando entre 29 y 798 días. La curva de Kaplan-Meier indicó que el cáncer empeoraba cuanto mayor era el retraso entre el diagnóstico y la cirugía. Los pacientes sometidos a cirugía dentro de los 60 días tenían aproximadamente un 95% de probabilidad de no aumentar el riesgo inicial de recurrencia. Esta cifra cayó al 80%, 70% y 50% en los pacientes operados hasta 100, 120 y 180 días, respectivamente. Conclusión: El retraso en la realización de la PR representa un riesgo continuo de restablecimiento de la neoplasia. El momento ideal para la PR es hasta los 60 días desde la biopsia de próstata, ya que la probabilidad de upstaging es inferior al 5% en este periodo.Introdução: De acordo com a literatura, não há consenso sobre um tempo de atraso razoável desde o diagnóstico até a operação da prostatectomia radical (PR) sem piora do prognóstico. Objetivo: Avaliar a influência desse tempo no risco de recorrência da doença em pacientes com adenocarcinoma acinar da próstata tratados com PR. Método: Quatrocentos e doze pacientes submetidos à PR foram avaliados retrospectivamente. Destes, 172 foram excluídos por dados incompletos e outros 28, por estadiamento pré- -operatório como câncer de próstata de alto risco (PSA > 10 ng/mL ou escore de Gleason na biópsia > 7). Os estadiamentos pré e pós-operatórios foram comparados, e a análise de sobrevida feita pelo método de Kaplan-Meier para examinar a influência do tempo na discordância entre os estadiamentos pré e pós-operatórios. Resultados: Para os 212 pacientes da amostra, o tempo médio desde o diagnóstico até a PR foi de 176,1 ± 120,2 dias (mediana de 145,5 dias), variando de 29 a um máximo de 798 dias. A curva de Kaplan-Meier indicou que o câncer piorava quanto maior o atraso entre o diagnóstico e a operação. Pacientes submetidos à cirurgia dentro de 60 dias tiveram cerca de 95% de probabilidade de não aumentarem o risco inicial de recorrência. Esse número caiu para 80%, 70% e 50% nos pacientes operados em até 100, 120 e 180 dias, respectivamente. Conclusão: O atraso na realização da PR representa risco contínuo de recorrência da neoplasia. O tempo ideal para PR é de até 60 dias a partir da biópsia da próstata, uma vez que a probabilidade de upstaging é inferior a 5% nesse período.INCA2024-02-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/440610.32635/2176-9745.RBC.2024v70n1.4406Revista Brasileira de Cancerologia; Vol. 70 No. 1 (2024): Jan./Feb./Mar.; e-024406Revista Brasileira de Cancerologia; Vol. 70 Núm. 1 (2024): ene./feb./mar.; e-024406Revista Brasileira de Cancerologia; v. 70 n. 1 (2024): jan./fev./mar.; e-0244062176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAenghttps://rbc.inca.gov.br/index.php/revista/article/view/4406/3351https://rbc.inca.gov.br/index.php/revista/article/view/4406/3359Copyright (c) 2024 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessVeloso, Denny Fabrício MagalhãesVeloso, Denise SenaAndrade, André Felipe Zuccolo Barragat de2024-03-27T17:34:02Zoai:rbc.inca.gov.br:article/4406Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2024-03-27T17:34:02Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
Relación entre el Tiempo de Demora Hasta el Tratamiento Quirúrgico del Cáncer de Próstata y el Riesgo de Recurrencia de la Enfermedad
Relação entre Tempo de Atraso no Tratamento Cirúrgico do Câncer de Próstata e Risco de Recorrência da Doença
title Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
spellingShingle Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
Veloso, Denny Fabrício Magalhães
Neoplasias da Próstata
Prostatectomia
Tempo para o Tratamento
Progressão da Doença
Recidiva Local de Neoplasia
Prostatic Neoplasms
Prostatectomy
Time-to-Treatment
Disease Progression
Neoplasm Recurrence, Local
Neoplasias de la Próstata
Prostatectomía
Tiempo de Tratamiento
Progresión de la Enfermedad
Recurrencia Local de Neoplasia
title_short Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
title_full Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
title_fullStr Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
title_full_unstemmed Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
title_sort Relation between Delay Time to Surgical Treatment of Prostate Cancer and Disease Recurrence Risk
author Veloso, Denny Fabrício Magalhães
author_facet Veloso, Denny Fabrício Magalhães
Veloso, Denise Sena
Andrade, André Felipe Zuccolo Barragat de
author_role author
author2 Veloso, Denise Sena
Andrade, André Felipe Zuccolo Barragat de
author2_role author
author
dc.contributor.author.fl_str_mv Veloso, Denny Fabrício Magalhães
Veloso, Denise Sena
Andrade, André Felipe Zuccolo Barragat de
dc.subject.por.fl_str_mv Neoplasias da Próstata
Prostatectomia
Tempo para o Tratamento
Progressão da Doença
Recidiva Local de Neoplasia
Prostatic Neoplasms
Prostatectomy
Time-to-Treatment
Disease Progression
Neoplasm Recurrence, Local
Neoplasias de la Próstata
Prostatectomía
Tiempo de Tratamiento
Progresión de la Enfermedad
Recurrencia Local de Neoplasia
topic Neoplasias da Próstata
Prostatectomia
Tempo para o Tratamento
Progressão da Doença
Recidiva Local de Neoplasia
Prostatic Neoplasms
Prostatectomy
Time-to-Treatment
Disease Progression
Neoplasm Recurrence, Local
Neoplasias de la Próstata
Prostatectomía
Tiempo de Tratamiento
Progresión de la Enfermedad
Recurrencia Local de Neoplasia
description Introduction: There is no consensus in the literature on a reasonable delay time from diagnosis to radical prostatectomy (RP) surgery, without worsening the prognosis. Objective: To evaluate the influence of the delay on the risk of disease recurrence in patients with acinar adenocarcinoma of the prostate treated with RP. Method: Four hundred and twelve patients undergoing RP were retrospectively evaluated. Of these, 172 were excluded due to incomplete data and another 28 due to preoperative staging as high-risk prostate cancer (PSA > 10 ng/mL or Gleason score on biopsy > 7). Pre-and postoperative stagings were compared and survival analysis was performed using the Kaplan-Meier method to investigate the influence of time on discordance between pre- and postoperative stagings. Results: For the 212 patients of the sample, the average time from diagnosis to RP was 176.1 ± 120.2 days (median 145.5 days), ranging from 29 to a maximum of 798 days. The Kaplan-Meier curve indicated that the cancer worsened the longer the delay between diagnosis and surgery. Patients undergoing surgery within 60 days had an approximately 95% probability of not increasing the initial risk of recurrence. This number fell to 80%, 70% and 50% in patients operated on up to 100, 120 and 180 days, respectively. Conclusion: Delay in performing RP represents a continuous risk of relapse. The ideal time for RP is up to 60 days from prostate biopsy, as the probability of upstaging is less than 5% in this period.
publishDate 2024
dc.date.none.fl_str_mv 2024-02-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/4406
10.32635/2176-9745.RBC.2024v70n1.4406
url https://rbc.inca.gov.br/index.php/revista/article/view/4406
identifier_str_mv 10.32635/2176-9745.RBC.2024v70n1.4406
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/4406/3351
https://rbc.inca.gov.br/index.php/revista/article/view/4406/3359
dc.rights.driver.fl_str_mv Copyright (c) 2024 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2024 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 70 No. 1 (2024): Jan./Feb./Mar.; e-024406
Revista Brasileira de Cancerologia; Vol. 70 Núm. 1 (2024): ene./feb./mar.; e-024406
Revista Brasileira de Cancerologia; v. 70 n. 1 (2024): jan./fev./mar.; e-024406
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042241960673280